Novartis Flags Faster Sales and Profit Growth for 2015

Swiss drugmaker Novartis said sales and profits would rise at a faster pace this year as recent drug successes and its portfolio overhaul help it weather competition from cheaper generic medicines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.